
Oussama Wazni, MD, discusses the results of the OPTION trial examining LAAC in atrial fibrillation as well as its reception as AHA 2024.

Oussama Wazni, MD, is the vice chairman of Cardiovascular Medicine and section head of Cardiac Electrophysiology at the Cleveland Clinic.

Oussama Wazni, MD, discusses the results of the OPTION trial examining LAAC in atrial fibrillation as well as its reception as AHA 2024.